AnandRathi

Beryl Drugs Ltd Fundamental Analysis

Last Updated Date: 13 Oct 2026
₹23.51
-1.78 (-7.04%)

Beryl Drugs Ltd (Beryl Drugs) fundamental analysis breaks down the key financial metrics of the small-cap Pharmaceuticals company, which carries a market capitalisation of ₹12 crore.

Beryl Drugs Ltd Overview

Market cap₹12 Crs
Volume1,572
Prev. Close₹25.29
Year range₹15.92 - ₹27.60
ISININE415H01017

Beryl Drugs Ltd Fundamentals

ROCE(TTM)7.56%
P/E Ratio (TTM)19.11
P/B Ratio1.21
Debt to Equity0.25
ROE4.30%
EPS (TTM)1.23
Dividend Yield0.00%
Book Value19.45
Profit Margin2.91%
Operating Margin4.94%

Beryl Drugs Ltd Historical Performance

1 Month Return-2.00%
6 Month Return-1.43%
3 Year Return5.19%
3 Month Return6.96%
1 Year Return4.63%
5 Year Return72.23%

Beryl Drugs Ltd Share Price History

High:0.00
Low:0.00
No History Available

Disclaimer

The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...

Frequently Asked Questions

Download TradeMobi App

  • Real-Time Market Data
  • Advanced Trading Tools
  • Expert-Backed Research